What Painkillers Can I Take With COPD?

Acetaminophen (paracetamol) is generally the safest first-line painkiller for people living with COPD, because it does not suppress breathing the way opioids can and carries fewer cardiovascular and gastrointestinal risks than most anti-inflammatory drugs. That said, the choice is rarely as simple as one pill for every situation. COPD changes the risk profile of nearly every class of pain medication, and the answer depends on the type of pain, the severity of your lung disease, and what other medications you already take.

Why Pain Is So Common in COPD

If you have COPD and also deal with chronic pain, you are far from alone. A systematic review and meta-analysis found that pain prevalence among COPD patients in high-quality studies ranged from roughly 32 to 60 percent, consistently higher than in the general population.¹ A study comparing COPD patients directly with a matched general population sample found that about 45 percent of those with COPD reported pain, compared with 34 percent in the general population after adjusting for age and sex.² The pain tends to cluster in the chest, upper back, shoulders, and neck, areas that take a beating from the extra work of breathing with damaged lungs.³

Musculoskeletal strain from chronic coughing, hyperinflated lungs pushing on the rib cage, osteoporosis from long-term corticosteroid use, and inactivity-related stiffness all contribute. The point is not just that COPD patients hurt, it is that many of them need pain relief regularly, which makes the question of safe painkillers practical and urgent rather than academic.

Acetaminophen as the Starting Point

Acetaminophen (known as paracetamol outside the United States) is the default first choice for mild-to-moderate pain in COPD. It does not act on prostaglandins in the stomach lining the way NSAIDs do, so it avoids the gastrointestinal bleeding risk. And unlike opioids, it has no direct effect on the brain’s respiratory drive. For most people with COPD, standard doses for a short course pose no special lung-related hazard.

A cohort study in elderly Australians with COPD looked specifically at whether paracetamol use affected the risk of COPD exacerbations. Current use at the maximum daily dose of 4 grams for about a week was actually associated with a lower risk of exacerbation compared with non-use. After about 30 days, though, the risk edged above baseline before returning to normal around the two-month mark.⁴ That finding is from a single observational study and should not be over-interpreted, but it does suggest that short-term acetaminophen use is not something COPD patients need to fear.

The main caveat with acetaminophen has nothing to do with your lungs: it is processed by your liver, so people with liver disease or heavy alcohol use need to stay well under the 4-gram daily maximum. If you are already taking combination cold or flu products that contain acetaminophen, doubling up accidentally is a real hazard.

NSAIDs and Aspirin

Non-steroidal anti-inflammatory drugs like ibuprofen and naproxen are the other common over-the-counter option. For most COPD patients without asthma overlap, an occasional NSAID for a headache or a sore joint is not dangerous. The worry historically comes from aspirin-exacerbated respiratory disease, a condition where aspirin and NSAIDs trigger wheezing and nasal symptoms. That condition is strongly linked to asthma, particularly asthma with nasal polyps, and not to COPD alone. If your doctor has told you that you have an overlap of both asthma and COPD, or if you have ever noticed worsening breathing after taking ibuprofen, then NSAIDs deserve extra caution.

Aspirin itself has an interesting relationship with COPD. A propensity-matched analysis from the SPIROMICS cohort found that daily aspirin users had a lower rate of total COPD exacerbations, along with modestly better scores on respiratory symptom questionnaires and reduced odds of moderate-to-severe breathlessness.⁵ That does not mean you should start taking daily aspirin for your COPD. The finding likely reflects aspirin’s anti-inflammatory properties, and the study was observational, not a trial designed to prove cause and effect. But it is reassuring if you already take low-dose aspirin for cardiovascular reasons.

The real concerns with longer-term NSAID use are the same as for anyone: stomach ulcers, kidney stress, and cardiovascular risk, particularly at higher doses or with daily use. Because COPD patients are often older and frequently take other medications like oral corticosteroids, they are at higher background risk for GI bleeding. The practical rule is to use the lowest effective dose for the shortest time needed, and to check with your prescriber before making NSAIDs a regular habit.

Why Opioids Are a Different Conversation

Opioids are where the risk calculus changes sharply for anyone with compromised lungs. All opioids, from codeine to oxycodone to morphine, suppress the brainstem’s respiratory drive to some degree. In a person whose lungs already struggle to exchange oxygen and carbon dioxide efficiently, that suppression can be dangerous.

A study of older adults with COPD found that even transient opioid exposure (a short prescription, not chronic use) was associated with a roughly 76 percent increase in the odds of an acute COPD exacerbation. Each bump in dose made things worse: every 25 milligram increase in morphine-equivalent dose carried an additional 18 percent increase in exacerbation odds.⁶ The risk is compounded when opioids are combined with sedatives like benzodiazepines or certain sleep medications. Among Medicare beneficiaries with COPD, using an opioid together with a sedative for even 11 to 30 days was associated with more than a ninefold increase in the hazard of respiratory events compared with opioid-only use.⁷

None of this means opioids are categorically forbidden if you have COPD. It means the threshold for prescribing them should be higher, the doses lower, and the monitoring closer than for a person with healthy lungs. If you are sent home from the emergency room or a dental procedure with a short opioid prescription, the risk from a few days at a low dose is small. The danger escalates with higher doses, longer durations, and the addition of other sedating drugs.

When Low-Dose Opioids Are Actually Prescribed for COPD

There is a scenario where doctors deliberately prescribe opioids to COPD patients: refractory breathlessness, the crushing sensation of not getting enough air that persists even after all standard treatments are optimized. This is not about pain relief; it is about symptom control in advanced disease. But it illustrates what careful opioid use looks like in this population.

A randomized trial tested sustained-release morphine at low doses (up to 20 mg daily) for chronic breathlessness in COPD. The morphine group showed modest improvement in overall health status, and in those with the most severe breathlessness, worst breathlessness scores improved. Carbon dioxide levels did not rise meaningfully, and no morphine-related hospital admissions or deaths occurred.⁸ A follow-up analysis of adverse effects during the titration phase found that side effects were highest in the first week and dropped substantially by week three. Most side effects did not require stopping the drug or cutting the dose.⁹

The key distinction is that these are very low doses, carefully titrated, and closely monitored. The lesson for pain management is that if you and your doctor determine an opioid is unavoidable for severe pain, starting low and going slow with attentive follow-up can make it manageable. It is not a green light for self-medicating with leftover pills from a previous prescription.

What Opioids Can Do to Your Sleep

One underappreciated risk of opioids in COPD involves what happens while you are asleep. A randomized trial measuring the overnight effects of low-dose morphine in COPD found that morphine reduced mean and lowest overnight oxygen saturation by about 2 percent and 5 percent respectively, and raised carbon dioxide levels during sleep by over 3 mm Hg compared with placebo. More than 40 percent of participants on morphine met clinical criteria for nighttime hypoventilation, compared with about 20 percent on placebo.¹⁰

If you already use supplemental oxygen at night or have been told your oxygen dips while you sleep, this matters. Even a modest dip in oxygen saturation can be clinically meaningful in someone whose baseline is already low. If an opioid is prescribed, your doctor may want to check your overnight oxygen levels, particularly if you notice increased morning headaches or grogginess, both signs of CO2 retention.

Gabapentin and Pregabalin Deserve Extra Caution

Gabapentin and pregabalin are not traditional painkillers, but they are commonly prescribed for nerve pain, fibromyalgia, and other chronic pain conditions. Many people with COPD take them without realizing they carry their own respiratory risks. In December 2019, the U.S. FDA issued a warning that gabapentinoids can cause serious breathing difficulties, particularly in people with respiratory risk factors such as COPD, and especially when combined with opioids or other central nervous system depressants.¹¹

If you are taking gabapentin or pregabalin for chronic pain and you also have COPD, do not stop them abruptly without talking to your doctor, as withdrawal can be unpleasant. But make sure whoever manages your COPD is aware that you take them, and watch for new or worsening shortness of breath after a dose increase.

Pain Management Around Surgery

Surgery creates a very different pain problem for COPD patients. Postoperative pain that is not well controlled leads to shallow breathing, inability to cough effectively, and a higher risk of pneumonia and respiratory failure. But aggressive opioid-based pain control suppresses the respiratory drive. Striking the right balance is one of the core challenges of perioperative care in COPD.

The current approach favors what is called multimodal analgesia: combining smaller doses of several different types of painkillers (typically acetaminophen, an NSAID, and a regional nerve block) rather than relying on one large opioid dose. By spreading the pain relief across different mechanisms, each individual drug can be kept at a lower dose, reducing the chance of respiratory depression while still controlling pain well enough for the patient to breathe deeply and cough.¹² Regional anesthetic techniques, such as epidural blocks or nerve blocks, are particularly valuable in COPD because they can numb a specific area without affecting overall breathing.¹³

If you have COPD and are facing elective surgery, it is worth asking your anesthesiologist ahead of time about their plan for postoperative pain control. Patient-controlled analgesia, where you press a button for small doses rather than waiting for a nurse to bring a pill, is preferred over “as-needed” orders because it keeps pain consistently controlled at lower total doses.¹⁴

What About Non-Drug Pain Relief?

Given the complications that medications can create, you might hope that pulmonary rehabilitation, one of the most effective interventions for COPD overall, would also help with pain. The evidence here is disappointing. A study that tracked chronic pain through a standard pulmonary rehabilitation program found no significant change in pain intensity, anxiety, depression, or pain coping strategies after the program was complete.¹⁵ Pulmonary rehab improves exercise capacity, breathlessness, and quality of life, but if you enter it with chronic pain, you will probably still have that pain when you leave.

That does not mean non-drug options are useless. Physical therapy targeted specifically at pain (as opposed to general pulmonary rehab), gentle strengthening exercises for the muscles of the trunk and shoulders, heat or cold therapy, and transcutaneous electrical nerve stimulation (TENS) are all safe for COPD patients. None of them interact with your lungs or your medications. They are reasonable complements to careful pharmacological management rather than replacements for it.

Muscle Relaxants and Sedating Drugs

Muscle relaxants like cyclobenzaprine, methocarbamol, and tizanidine are sometimes prescribed for back spasms or musculoskeletal pain. Most of them work partly through sedation, and that sedating effect can compound the respiratory risks already present in COPD. Research on neuromuscular blocking agents (a different, intravenous class used in ICU settings) has shown that COPD patients lose intercostal muscle mass faster than control patients when these agents are administered, highlighting the sensitivity of COPD patients’ respiratory muscles to pharmacological interference.¹⁶ While the oral muscle relaxants your doctor might prescribe at home are much milder than ICU drugs, the general principle holds: anything that sedates you or relaxes the muscles involved in breathing deserves extra respect when your lung function is already limited.

If you need a muscle relaxant, your prescriber should start with the lowest effective dose and avoid combining it with opioids, gabapentinoids, or benzodiazepines. Taking it at bedtime rather than during the day can help, though this creates the overlap with the sleep-related breathing concerns described earlier.

Practical Takeaways for Everyday Decisions

For a headache, menstrual cramps, or garden-variety back pain, acetaminophen remains the least complicated choice. If it is not enough on its own, a short course of an NSAID like ibuprofen is reasonable for most COPD patients who do not have kidney disease, a history of GI bleeding, or an asthma-COPD overlap with known NSAID sensitivity. Beyond that, the decision tree branches quickly into territory where your specific medical history matters more than any general guideline.

A few practical habits can reduce your risk regardless of which painkiller you use:

Keep a medication list: Bring every bottle, including over-the-counter products and supplements, to your appointments. Drug interactions are the biggest hidden hazard.
Avoid stacking sedation: If you take a benzodiazepine for anxiety, an antihistamine for allergies, and a gabapentinoid for nerve pain, adding even a mild opioid on top can create cumulative respiratory depression that none of those drugs would cause alone.
Monitor nighttime symptoms: Morning headaches, unusual grogginess, or a partner noticing pauses in your breathing can signal that a painkiller is affecting your breathing during sleep.
Do not borrow prescriptions: A dose of oxycodone that is routine for your friend with healthy lungs could be hazardous for you. Opioid dosing in COPD needs to be individualized.

When Pain Itself Makes COPD Worse

One angle that often gets overlooked is the feedback loop between pain and COPD symptoms. Uncontrolled pain makes people breathe shallowly, avoid physical activity, sleep poorly, and become anxious, all of which worsen COPD outcomes. The systematic review on pain in COPD noted that pain was associated with poorer quality of life and more severe symptoms across multiple measures.¹ And in one study, COPD patients with chest or upper back pain showed greater lung hyperinflation than those without pain, suggesting that the mechanical distortion of the chest wall itself may be both a cause and a consequence of the pain.³

The implication is that undertreating pain out of fear of medication side effects can itself be harmful. A COPD patient who avoids all painkillers and instead lies in bed guarding against chest wall pain may end up with more atelectasis, more deconditioning, and more exacerbations than one who takes a thoughtful, low-risk analgesic. The goal is not to avoid all medications but to choose the right ones, at the right doses, with eyes open about the trade-offs.